We verified that SLAMF7 mRNA levels were downregulated in the carfilzomib-resistant MM derivatives in accord with the less differentiated plasma cell phenotype revealed by GSEA analysis above. The gene discussed is SLAMF7; the disease is Miyoshi myopathy.